Hormonal
Tirzepatide, a dual GIP and GLP-1 receptor agonist, produces significant weight loss (15-21%) in adults with obesity when administered weekly alongside lifestyle modifications.
If you have obesity or are overweight with related health issues, Tirzepatide is a once-weekly injection that works by mimicking hormones to reduce appetite and slow digestion. In clinical trials, patients lost 15-21% of their body weight over 72 weeks when combining the drug with diet and exercise. While nausea and diarrhea are common side effects, they affect a minority of users. This treatment is intended for long-term management, not short-term fixes.
After 72 weeks, there was an average weight loss correlated with the Tirzepatide dose (5mg, 10mg, 15mg), resulting in 15%, 19.5%, and 20.9%, respectively. Meanwhile, the placebo group showed a weight loss of 3.1%.
Why this rating
Based on Phase III clinical trials (SURMOUNT-1) with a large sample size (n=2539), though it is a review summarizing these trials rather than a primary data publication.
Source
Will Tirzepatide become a game-changer in the pharmacological treatment of obesity? - literature review
Aleksandra Doryń et al. · Journal of Education Health and Sport · 2024
DOI 10.12775/jehs.2024.71.49544
Related findings · Hormonal
- Initial treatment for type 2 diabetes should be a combination of metformin and either an SGLT-2 inhibitor or a GLP-1 receptor agonist to achieve cardiorenal protection, rather than monotherapy or older agents like sulfonylureas.Strong
- For patients with specific monogenic obesity syndromes (leptin deficiency, POMC/PCSK1/LEPR mutations), targeted pharmacotherapy (recombinant leptin or setmelanotide) is highly effective and should be prioritized, unlike in polygenic obesity.Strong
- Continued weekly administration of 2.4 mg subcutaneous semaglutide prevents weight regain and promotes further weight loss in adults with overweight or obesity, whereas switching to placebo results in significant weight regain.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →